The company in question is, Allergan plc (NYSE:AGN) currently with a stock price of 246.8 (-2.78% today). The market cap for Allergan plc is 99341.66, and is in the sector Healthcare, and Drugs – Generic industry. The target price for Allergan plc is 292.07. Currently Allergan plc is trading with a P/E of *TBA, and a forward P/E of 14.49. Average volume for Allergan plc is 3552.8 and so far today it is 4265498.
Performance in the last year for Allergan plc has been -20.54%. For EPS growth, Allergan plc has seen a growth of 23.00%, and is looking to grow in the next year to 23.64%. More long term stats show that EPS growth has been -50.40% over the last five years and could be 10.80% for the next five years. Allergan plc has seen sales growth quarter over quarter at -44.20%, with EPS growth quarter over quarter at 91.80%. The 20-day simple moving average is 2.07%, with the 200-day simple moving average coming to -7.89%.
Since the IPO date for Allergan plc on the 2/17/1993, Allergan plc has seen performance year to date to be -18.77%. With Allergan plc trading at 246.8, the dividend yield is *TBA, and the EPS is -5.63.
So could Allergan plc, be undervalued? Well as said before P/E is *TBA. The PEG is *TBA, P/S is 6.09 and the P/B is at 1.38. The P/cash is 43.69, with P/free cash flow at *TBA.
Allergan plc ability to deal with debt shows that the current ratio is 1, and the quick ratio is 0.9. This is with long term debt/equity at 0.53, and total debt/equity at 0.59.
In terms of margins, Allergan plc has a gross margin of 71.80%, an operating margin of *TBA and a profit margin of *TBA.Payout ratio for Allergan plc is *TBA. Return on assets come to *TBA with return on investment coming to -1.30%.
Insider ownership for Allergan plc, is at 0.10% and institutional ownership comes to 90.90%. Outstanding shares are at 391.34. While shares float is 391.34. The float short is currently 1.45%, and short ratio is 1.6.